196 related articles for article (PubMed ID: 7083725)
41. Pharmacokinetics of piperacillin in patients on peritoneal dialysis with and without peritonitis.
Debruyne D; Ryckelynck JP; Hurault De Ligny B; Moulin M
J Pharm Sci; 1990 Feb; 79(2):99-102. PubMed ID: 2324971
[TBL] [Abstract][Full Text] [Related]
42. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.
de Fijter CW; Verbrugh HA; Oe LP; Peters ED; van der Meulen J; Donker AJ; Verhoef J
Kidney Int; 1992 Oct; 42(4):947-50. PubMed ID: 1453585
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW
Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
45. Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
Morse G; Janicke D; Cafarell R; Piontek K; Apicella M; Jusko WJ; Walshe J
Clin Pharmacol Ther; 1985 Aug; 38(2):150-6. PubMed ID: 4017417
[TBL] [Abstract][Full Text] [Related]
46. Ciprofloxacin in plasma and peritoneal dialysate after oral therapy in patients on continuous ambulatory peritoneal dialysis.
Fleming LW; Moreland TA; Scott AC; Stewart WK; White LO
J Antimicrob Chemother; 1987 Apr; 19(4):493-503. PubMed ID: 3583969
[TBL] [Abstract][Full Text] [Related]
47. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
Brouard R; Tozer TN; Merdjan H; Guillemin A; Baumelou A
Clin Nephrol; 1988 Oct; 30(4):197-206. PubMed ID: 3214965
[TBL] [Abstract][Full Text] [Related]
48. [The effect of the number of peritonitis episodes on peritoneal membrane function].
Jovanović D; Nesić V; Dimitrijević Z
Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
[TBL] [Abstract][Full Text] [Related]
49. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Montañés Pauls B; Almiñana MA; Casabó Alós VG
Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
[TBL] [Abstract][Full Text] [Related]
50. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
[TBL] [Abstract][Full Text] [Related]
51. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
Lye WC; Wong PL; van der Straaten JC; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():179-81. PubMed ID: 8534699
[TBL] [Abstract][Full Text] [Related]
52. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis.
Gendeh BS; Said H; Gibb AG; Aziz NS; Kong N; Zahir ZM
J Laryngol Otol; 1993 Aug; 107(8):681-5. PubMed ID: 8409715
[TBL] [Abstract][Full Text] [Related]
53. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic modeling of bidirectional transfer during peritoneal dialysis.
Janicke DM; Morse GD; Apicella MA; Jusko WJ; Walshe JJ
Clin Pharmacol Ther; 1986 Aug; 40(2):209-18. PubMed ID: 3731683
[TBL] [Abstract][Full Text] [Related]
56. Peritoneal transport of vancomycin in 4 patients undergoing continuous ambulatory peritoneal dialysis.
Pancorbo S; Comty C
Nephron; 1982; 31(1):37-9. PubMed ID: 7110474
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
Grabe DW; Bailie GR; Eisele G; Frye RF
Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
[TBL] [Abstract][Full Text] [Related]
58. Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.
Cheng IK; Chau PY; Kumana CR; Chan CY; Kou M; Siu LK
Perit Dial Int; 1993; 13 Suppl 2():S383-5. PubMed ID: 8399617
[TBL] [Abstract][Full Text] [Related]
59. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis.
Joffe P; Henriksen JH
Nephrol Dial Transplant; 1995; 10(9):1725-32. PubMed ID: 8559496
[TBL] [Abstract][Full Text] [Related]
60. Compatibility of cefazolin and gentamicin in peritoneal dialysis solutions.
Walker PC; Kaufmann RE; Massoud N
Drug Intell Clin Pharm; 1986 Sep; 20(9):697-700. PubMed ID: 3757783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
